Advertisement
Screener

TECTONIC THERAPEUTIC, INC. (TECX) Graph

TECX Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Research and development $18.05M; Selling, general and administrative (m); Operating expenses $24.22M; Income tax $77.00K.
  • 2026-03-31: Research and development $20.87M; Selling, general and administrative (m); Operating expenses $27.30M; Income tax (m).
  • 2025-12-31: Research and development $16.34M*; Selling, general and administrative (m); Operating expenses $21.52M*; Income tax $254.00K*.
  • 2025-09-30: Research and development $16.93M; Selling, general and administrative (m); Operating expenses $21.89M; Income tax $0.00.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$18.05M(m)$24.22M$77.00K-$22.29M
2026-03-31$20.87M(m)$27.30M(m)-$25.24M
2025-12-31$16.34M*(m)$21.52M*$254.00K*-$74.10B*
2025-09-30$16.93M(m)$21.89M$0.00-$19.04M
2025-06-30$17.18M(m)$22.33M$976.00K-$19.98M
2025-03-31$13.04M(m)$18.30M(m)-$15.91M
2024-09-30$14.32M(m)$19.64M$0.00-$17.72M
2024-06-30$7.07M$9.90M$11.42M$0.00-$12.67M
2024-03-31$10.82M(m)$12.97M(m)-$15.22M
2023-09-30$8.13M(m)$10.11M$0.00-$10.05M
2023-06-30$8.77M(m)$10.63M$0.00-$10.46M
2023-03-31$17.33M(m)$25.22M(m)-$14.45M
2022-09-30$15.92M(m)$22.98M(m)-$22.97M
2022-06-30$18.88M(m)$27.77M(m)-$28.05M
2022-03-31$19.25M(m)$29.42M(m)-$29.83M
2021-09-30$23.04M(m)$32.62M(m)-$32.61M
2021-06-30$22.54M(m)$31.38M(m)-$31.39M
2021-03-31$18.53M(m)$26.88M(m)-$26.90M
2020-09-30$28.51M(m)$36.72M(m)-$36.78M
2020-06-30$20.87M(m)$28.86M(m)-$28.83M
2020-03-31$18.27M(m)$26.59M(m)-$25.97M
2019-09-30$13.04M(m)$18.06M(m)-$17.14M
2019-06-30$12.27M(m)$16.61M(m)-$16.05M
2019-03-31$12.45M(m)$17.70M(m)-$17.10M
2018-09-30$9.23M(m)$12.23M(m)-$11.59M
2018-06-30$7.41M(m)$9.55M(m)-$10.51M
2018-03-31$5.65M(m)$7.79M(m)-$8.24M
2017-09-30$5.41M(m)$6.37M(m)-$6.44M
2017-06-30$1.88M(m)$2.54M(m)-$2.53M

Revenue and expense 6 month

Period endResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$38.92M(m)$51.52M$77.00K-$47.53M
2025-06-30$30.22M(m)$40.63M$976.00K-$35.89M
2024-06-30$17.89M$9.90M$24.39M$0.00-$27.89M
2023-06-30$21.75M(m)$25.16M$0.00-$24.90M
2022-06-30$38.13M(m)$57.19M(m)-$57.89M
2021-06-30$41.02M(m)$58.26M(m)-$58.29M
2020-06-30$39.14M(m)$55.45M(m)-$54.80M
2019-06-30$24.71M(m)$34.31M(m)-$33.16M
2018-06-30$13.05M(m)$17.34M(m)-$18.75M
2017-06-30$3.31M(m)$4.59M(m)-$4.61M

Revenue and expense 9 month

Period endResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$47.15M(m)$62.52M$976.00K-$54.92M
2024-09-30$32.21M$9.90M$44.02M$0.00-$45.61M
2023-09-30$29.77M(m)$35.27M$0.00-$34.95M
2022-09-30$54.05M(m)$80.18M(m)-$80.86M
2021-09-30$64.11M(m)$90.88M(m)-$90.90M
2020-09-30$67.65M(m)$92.16M(m)-$91.58M
2019-09-30$37.76M(m)$52.38M(m)-$50.30M
2018-09-30$22.29M(m)$29.57M(m)-$30.34M
2017-09-30$8.73M(m)$10.96M(m)-$11.05M

Revenue and expense 12 month

Period endResearch and developmentOperating expensesIncome taxNet income
2025-12-31$63.49M$84.04M$1.23M-$74.15B
2024-12-31$41.36M$58.02M$0.00-$57.98B
2023-12-31$36.97M$44.65M$0.00-$42.82B
2022-12-31$72.19M$105.43M$0.00-$105.89M
2021-12-31$83.11M$118.84M(m)-$119.13M
2020-12-31$87.24M$120.23M(m)-$119.71M
2019-12-31$54.97M$75.81M(m)-$72.97M
2018-12-31$35.09M$46.24M(m)-$46.36M
2017-12-31$15.19M$18.39M(m)-$18.65M

Similar stocks

Stock NameCountryMarket CapPE Ratio
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Entera Bio Ltd. (ENTX)$0.485B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
AGENUS INC (AGEN)United States$0.383B1.41